SUTRO BIOPHARMA, INC. (STRO) Form 10-K Annual Reports
SUTRO BIOPHARMA, INC. (STRO) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: STRO
CIK: 1382101
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerMichael Formolo
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-22 | 2026-09-18 | 4 Filing | 0001992979-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352649 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005498 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345748 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345733 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003158 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001587487-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001294939-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001217412-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001536193-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001554591-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001891841-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001601264-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001236537-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-05 | 8-K | 0001193125-26-261658 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-02 | 4 Filing | 0001761333-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001699737-26-000010 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001907884-26-000008 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-224170 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-224065 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001011438-26-000314 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-01 | — | SCHEDULE 13G Filing | 0000919574-26-002548 | View SEC Doc Filr Page |
| ARS | 2026-04-22 | 2025-12-31 | ARS | 0001140361-26-016150 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-22 | — | DEFA14A | 0001193125-26-170441 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-22 | 2026-06-05 | DEF 14A | 0001193125-26-170354 | View SEC Doc Filr Page |